GRP
RNTX

Global Retirement Partners’s Rein Therapeutics RNTX Stock Holding History

Global Retirement Partners’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$22.4K Buy
19,316
+12,116
+168% +$16.7K ﹤0.01% 2818
2025
Q3 		$8.24K Hold
7,200
– – ﹤0.01% 2773
2025
Q2 		$10.1K Buy
+7,200
New +$13K ﹤0.01% 2603

Other funds holding RNTX

VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Global Retirement Partners's RNTX Position: Q4 2025 in Review

Global Retirement Partners increased its Rein Therapeutics (RNTX) stake by 168% in Q4 2025, buying an estimated $16.7K and bringing the position to 19,316 shares worth $22.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2818.

Global Retirement Partners first reported a position in RNTX in Q2 2025 and has held it in 3 quarters since. 48 funds tracked by Wall St. Rank hold RNTX as of Q4 2025.

  • Global Retirement Partners held 19,316 shares of Rein Therapeutics worth $22.4K as of Q4 2025.
  • Global Retirement Partners bought 12,116 Rein Therapeutics shares in Q4 2025, an estimated $16.7K.
  • Rein Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #2818 holding.
  • Global Retirement Partners first reported a position in Rein Therapeutics in Q2 2025 and has held it in 3 quarters since.
  • 48 funds tracked by Wall St. Rank held Rein Therapeutics as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.